Joseph Galanko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joseph Galanko has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Christopher Martin
7 shared publications- Robert S. Sandler
Division of Gastroenterology and Hepatology, The University of North Carolina, Chapel Hill, North Carolina, USA
6 shared publications - Temitope O. Keku
Center for Gastrointestinal Disease and Biology, University of North Carolina, Chapel Hill, NC 27599, USA
5 shared publications Robert Sandler
4 shared publications- Anne F. Peery
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina
3 shared publications - Dawn Provenzale
Department of Medicine, Duke University Medical Center, Durham Veterans Administration Medical Center, Box 3913, Durham, NC, 27710, USA
3 shared publications
Latest Publications
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S357-S358
Variations in Therapy for Inflammatory Bowel Disease among African American Patients Compared to other Racial Groups
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S357-S358
Variations in Therapy for Inflammatory Bowel Disease among African American Patients Compared to other Racial Groups
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S797
Self-Report is not a Sensitive Method of Assessing Depression in Patients with Inflammatory Bowel Disease
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S797
Self-Report is not a Sensitive Method of Assessing Depression in Patients with Inflammatory Bowel Disease
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S230-S231
1135 Colonic Diverticula Are Associated with Irritable Bowel Syndrome
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S230-S231
1135 Colonic Diverticula Are Associated with Irritable Bowel Syndrome
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S10
28 Obesity Is a Risk Factor for Colonic Diverticulosis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S10
28 Obesity Is a Risk Factor for Colonic Diverticulosis
- 1 April 2014
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 762, 24-31
Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk
- 1 April 2014
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 762, 24-31
Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk
- 12 November 2013
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 142 (3) , 489-503
Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer
Obesity is associated with basal-like breast cancer (BBC), an aggressive breast cancer subtype. The objective of this study was to determine whether obesity promotes BBC onset in adulthood and to evaluate the role of stromal–epithelial interactions in obesity-associated tumorigenesis. We hypothesized that hepatocyte growth factor (HGF) plays a promoting role in BBC, which express the HGF receptor, c-Met. In C3(1)-TAg mice, a murine model of BBC, we demonstrated that obesity leads to a significant increase in HGF secretion and an associated decrease in tumor latency. By immunohistochemical analysis, normal mammary gland exhibited obesity-induced HGF, c-Met and phospho-c-Met, indicating that the activation of the cascade was obesity-driven. HGF secretion was also increased from primary mammary fibroblasts isolated from normal mammary glands and tumors of obese mice compared to lean. These results demonstrate that obesity-induced elevation of HGF expression is a stable phenotype, maintained after several passages, and after removal of dietary stimulation. Conditioned media from primary tumor fibroblasts from obese mice drove tumor cell proliferation. In co-culture, neutralization of secreted HGF blunted tumor cell migration, further linking obesity-mediated HGF-dependent effects to in vitro measures of tumor aggressiveness. In sum, these results demonstrate that HGF/c-Met plays an important role in obesity-associated carcinogenesis. Understanding the effects of obesity on risk and progression is important given that epidemiologic studies imply a portion of BBC could be eliminated by reducing obesity.
- 12 November 2013
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 142 (3) , 489-503
Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer
Obesity is associated with basal-like breast cancer (BBC), an aggressive breast cancer subtype. The objective of this study was to determine whether obesity promotes BBC onset in adulthood and to evaluate the role of stromal–epithelial interactions in obesity-associated tumorigenesis. We hypothesized that hepatocyte growth factor (HGF) plays a promoting role in BBC, which express the HGF receptor, c-Met. In C3(1)-TAg mice, a murine model of BBC, we demonstrated that obesity leads to a significant increase in HGF secretion and an associated decrease in tumor latency. By immunohistochemical analysis, normal mammary gland exhibited obesity-induced HGF, c-Met and phospho-c-Met, indicating that the activation of the cascade was obesity-driven. HGF secretion was also increased from primary mammary fibroblasts isolated from normal mammary glands and tumors of obese mice compared to lean. These results demonstrate that obesity-induced elevation of HGF expression is a stable phenotype, maintained after several passages, and after removal of dietary stimulation. Conditioned media from primary tumor fibroblasts from obese mice drove tumor cell proliferation. In co-culture, neutralization of secreted HGF blunted tumor cell migration, further linking obesity-mediated HGF-dependent effects to in vitro measures of tumor aggressiveness. In sum, these results demonstrate that HGF/c-Met plays an important role in obesity-associated carcinogenesis. Understanding the effects of obesity on risk and progression is important given that epidemiologic studies imply a portion of BBC could be eliminated by reducing obesity.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1180 Constipation and a Low Fiber Diet Are Not Associated With Diverticulosis
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Tu1180 Constipation and a Low Fiber Diet Are Not Associated With Diverticulosis
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
467 PI3K Mutation in African Americans May Predict Worse Outcomes in Colorectal Cancer
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
467 PI3K Mutation in African Americans May Predict Worse Outcomes in Colorectal Cancer
- Open Access
- 5 September 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 389
Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
Background: Lower concentrations of the insulin–like growth factor binding protein-1 (IGFBP-1) and elevated concentrations of insulin or C-peptide have been associated with an increase in colorectal cancer risk (CRC). However few studies have evaluated IGFBP-1 and C-peptide in relation to adenomatous polyps, the only known precursor for CRC. Methods: Between November 2001 and December 2002, we examined associations between circulating concentrations of insulin, C-peptide, IGFBP-1 and apoptosis among 190 individuals with one or more adenomatous polyps and 488 with no adenomatous polyps using logistic regression models. Results: Individuals with the highest concentrations of C-peptide were more likely to have adenomas (OR = 2.2, 95% CI 1.4-4.0) than those with the lowest concentrations; associations that appeared to be stronger in men (OR = 4.4, 95% CI 1.7-10.9) than women. Individuals with high insulin concentrations also had a higher risk of adenomas (OR = 3.5, 95% CI 1.7-7.4), whereas higher levels of IGFBP-1 were associated with a reduced risk of adenomas in men only (OR = 0.3, 95% CI 0.1-0.7). Overweight and obese individuals with higher C-peptide levels (>1st Q) were at increased risk for lower apoptosis index (OR = 2.5, 95% CI 0.9-7.1), an association that remained strong in overweight and obese men (OR = 6.3, 95% CI 1.0-36.7). Higher levels of IGFBP-1 in overweight and obese individuals were associated with a reduced risk of low apoptosis (OR = 0.3, 95% CI 0.1-1.0). Conclusions: Associations between these peptides and the apoptosis index in overweight and obese individuals, suggest that the mechanism by which C-peptide could induce adenomas may include its anti-apoptotic properties. This study suggests that hyperinsulinemia and IGF hormones predict adenoma risk, and that outcomes associated with colorectal carcinogenesis maybe modified by gender.
- 5 September 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 389
Open AccessElevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
Background: Lower concentrations of the insulin–like growth factor binding protein-1 (IGFBP-1) and elevated concentrations of insulin or C-peptide have been associated with an increase in colorectal cancer risk (CRC). However few studies have evaluated IGFBP-1 and C-peptide in relation to adenomatous polyps, the only known precursor for CRC. Methods: Between November 2001 and December 2002, we examined associations between circulating concentrations of insulin, C-peptide, IGFBP-1 and apoptosis among 190 individuals with one or more adenomatous polyps and 488 with no adenomatous polyps using logistic regression models. Results: Individuals with the highest concentrations of C-peptide were more likely to have adenomas (OR = 2.2, 95% CI 1.4-4.0) than those with the lowest concentrations; associations that appeared to be stronger in men (OR = 4.4, 95% CI 1.7-10.9) than women. Individuals with high insulin concentrations also had a higher risk of adenomas (OR = 3.5, 95% CI 1.7-7.4), whereas higher levels of IGFBP-1 were associated with a reduced risk of adenomas in men only (OR = 0.3, 95% CI 0.1-0.7). Overweight and obese individuals with higher C-peptide levels (>1st Q) were at increased risk for lower apoptosis index (OR = 2.5, 95% CI 0.9-7.1), an association that remained strong in overweight and obese men (OR = 6.3, 95% CI 1.0-36.7). Higher levels of IGFBP-1 in overweight and obese individuals were associated with a reduced risk of low apoptosis (OR = 0.3, 95% CI 0.1-1.0). Conclusions: Associations between these peptides and the apoptosis index in overweight and obese individuals, suggest that the mechanism by which C-peptide could induce adenomas may include its anti-apoptotic properties. This study suggests that hyperinsulinemia and IGF hormones predict adenoma risk, and that outcomes associated with colorectal carcinogenesis maybe modified by gender.